{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:44:28Z","timestamp":1792021468477,"version":"4.4.0"},"reference-count":95,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin","award":["DS\/475\/22"],"award-info":[{"award-number":["DS\/475\/22"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epilepsy is a chronic disease of the central nervous system characterized by recurrent epileptic seizures. As a result of epileptic seizure or status epilepticus oxidants are excessively formed, which may be one of the causes of neuronal death. Given the role of oxidative stress in epileptogenesis, as well as the participation of this process in other neurological conditions, we decided to review the latest state of knowledge regarding the relationship between selected newer antiepileptic drugs (AEDs), also known as antiseizure drugs, and oxidative stress. The literature review indicates that drugs enhancing GABA-ergic transmission (e.g., vigabatrin, tiagabine, gabapentin, topiramate) or other antiepileptics (e.g., lamotrigine, levetiracetam) reduce neuronal oxidation markers. In particular, levetiracetam may produce ambiguous effects in this regard. However, when a GABA-enhancing drug was applied to the healthy tissue, it tended to increase oxidative stress markers in a dose-dependent manner. Studies on diazepam have shown that it exerts a neuroprotective effect in a \u201cU-shaped\u201d dose-dependent manner after excitotoxic or oxidative stress. Its lower concentrations are insufficient to protect against neuronal damage, while higher concentrations produce neurodegeneration. Therefore, a conclusion follows that newer AEDs, enhancing GABA-ergic neurotransmission, may act similarly to diazepam, causing neurodegeneration and oxidative stress when used in high doses.<\/jats:p>","DOI":"10.3390\/ijms24043873","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T03:09:21Z","timestamp":1676430561000},"page":"3873","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Second Generation of Antiepileptic Drugs and Oxidative Stress"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-8831","authenticated-orcid":false,"given":"Kamil","family":"Ko\u015bmider","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Kamieniak","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Miziak","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"Potschka","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yebeh.2009.10.023","article-title":"Hallmarks in the history of epilepsy: Epilepsy in antiquity","volume":"17","author":"Magiorkinis","year":"2010","journal-title":"Epilepsy Behav."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.seizure.2010.10.017","article-title":"Epilepsy stigma: Moving from a global problem to global solutions","volume":"19","year":"2010","journal-title":"Seizure"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11910-007-0053-z","article-title":"The neurobiology of epilepsy","volume":"7","author":"Scharfman","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fphar.2020.00020","article-title":"Vascular abnormalities and the role of vascular endothelial growth factor in the epileptic brain","volume":"11","author":"Ogaki","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: Scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","article-title":"Role of oxidative stress in epileptogenesis and potential implications for therapy","volume":"72","author":"Czuczwar","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"a022822","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Lukasiuk","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 Update","volume":"50","author":"Abelson","year":"2009","journal-title":"Epilepsia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199141060-00007","article-title":"Vigabatrin","volume":"41","author":"Grant","year":"1991","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/DMDI.2005.21.2.109","article-title":"The Effects of Vigabatrin on rat liver antioxidant status","volume":"21","author":"Cengiz","year":"2005","journal-title":"Drug. Metab. Drug. Interact."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/emmm.201303356","article-title":"Defects in GABA metabolism affect selective autophagy pathways and are alleviated by m TOR inhibition","volume":"6","author":"Lakhani","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/acn3.200","article-title":"Torin 1 partially corrects vigabatrin-induced mitochondrial increase in mouse","volume":"2","author":"Vogel","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4161\/15384101.2014.989114","article-title":"The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome","volume":"14","author":"Braat","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s11689-017-9184-y","article-title":"Acamprosate in a mouse model of fragile X syndrome: Modulation of spontaneous cortical activity, ERK1\/2 activation, locomotor behavior, and anxiety","volume":"9","author":"Schaefer","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J. Neurodev. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2006.08.057","article-title":"The co-treatments of vigabatrin and P2X receptor antagonists protect ischemic neuronal cell death in the gerbil hippocampus","volume":"1120","author":"Kim","year":"2006","journal-title":"Brain Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.STR.0000113691.32026.06","article-title":"Coactivation of GABA A and GABA B receptor results in neuroprotection during in vitro ischemia","volume":"35","author":"Costa","year":"2004","journal-title":"Stroke"},{"key":"ref_21","first-page":"36","article-title":"Hypoxia-induced changes of seizure susceptibility in immature rats are modified by vigabatrin","volume":"9","year":"2007","journal-title":"Epileptic Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.10603","article-title":"Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia","volume":"53","author":"Calabresi","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.6093256","article-title":"Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain","volume":"226","author":"Simon","year":"1984","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.wneu.2018.07.103","article-title":"Neuroprotective effects of vigabatrin on spinal cord ischemia-reperfusion injury","volume":"120","author":"Durdag","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1089\/neu.2017.5524","article-title":"Blood glutamate scavenger as a novel neuroprotective treatment in spinal cord injury","volume":"35","author":"Goldshmit","year":"2018","journal-title":"J. Neurotrauma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1734-1140(11)70497-2","article-title":"Basic mechanisms of antiepileptic drugs and their pharmacokinetic\/pharmacodynamic interactions: An update","volume":"63","author":"Rejdak","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/NDT.S6515","article-title":"Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients","volume":"6","author":"Czuczwar","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1742-7843.2009.00499.x","article-title":"Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats","volume":"106","author":"Arora","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4196\/kjpp.2014.18.3.269","article-title":"Lamotrigine decreased hippocampal damage and improved vascular risk markers in a rat model of pentylenetetrazole induced kindling seizure","volume":"18","author":"Haggag","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14740\/jocmr3289w","article-title":"Impact of oxidative stress and newer antiepileptic drugs on the albumin and cortisol value in severe motor and intellectual disabilities with epilepsy","volume":"10","author":"Morimoto","year":"2018","journal-title":"J. Clin. Med. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.1995.tb06009.x","article-title":"Tiagabine: The Safety Landscape","volume":"36","author":"Leppik","year":"1995","journal-title":"Epilepsia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","article-title":"3-Nitropropionic acid animal model and Huntington\u2019s disease","volume":"21","author":"Borlongan","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.pnpbp.2007.12.017","article-title":"Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats","volume":"32","author":"Dhir","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01206-4","article-title":"Biological effects of tiagabine on primary cortical astrocyte cultures of rat","volume":"288","author":"Cardile","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(01)01836-5","article-title":"Tiagabine treatment and DNA damage in rat astrocytes: An in vitro study by comet assay","volume":"306","author":"Cardile","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(02)02044-7","article-title":"Gabapentin inhibits presynaptic Ca2+ influx and synaptic transmission in rat hippocampus and neocortex","volume":"449","author":"Dougherty","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1528-1157.2000.tb00227.x","article-title":"Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients","volume":"41","author":"Petroff","year":"2000","journal-title":"Epilepsia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/ane.13075","article-title":"Therapeutic drug monitoring of gabapentin in various indications","volume":"139","author":"Kinge","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00002018-200023010-00003","article-title":"Adverse reactions to new anticonvulsant drugs","volume":"23","author":"Wong","year":"2000","journal-title":"Drug Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1745-7254.2005.00072.x","article-title":"Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats","volume":"26","author":"Baydas","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(03)00408-8","article-title":"Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats","volume":"35","author":"Baydas","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-8993(00)02426-4","article-title":"The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia","volume":"872","author":"Guyot","year":"2000","journal-title":"Brain Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0304-3959(99)00283-3","article-title":"Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn","volume":"85","author":"Shimoyama","year":"2000","journal-title":"Pain"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1358\/mf.2003.25.1.772547","article-title":"Mechanism of antinociceptive effect of nimodipine in experimental diabetic neuropathic pain","volume":"25","author":"Gupta","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(03)01294-9","article-title":"Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: Effects of vitamin E","volume":"462","author":"Baydas","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12640-019-00018-w","article-title":"Gabapentin attenuates oxidative stress and apoptosis in the diabetic rat retina","volume":"36","author":"Ola","year":"2019","journal-title":"Neurotox. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1101\/pdb.prot087312","article-title":"Detecting cleaved caspase-3 in apoptotic cells by flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00001756-199612200-00054","article-title":"BCL-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells","volume":"8","author":"Bonfoco","year":"1996","journal-title":"Neuroreport"},{"key":"ref_51","first-page":"159","article-title":"Gabapentin attenuates acute hypoxic stress-induced behavioral alterations and oxidative damage in mice: Possible involvement of GABAergic mechanism","volume":"46","author":"Kumar","year":"2008","journal-title":"Indian J. Exp. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1472-8206.2007.00524.x","article-title":"Possible involvement of GABAergic modulation in the protective effect of gabapentin against immobilization stress-induced behavior alterations and oxidative damage in mice","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","article-title":"Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity","volume":"674","author":"Kumar","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_54","first-page":"41","article-title":"Anticonvulsant drugs, oxidative stress and nitric oxide","volume":"54","year":"2011","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/0253-7613.132180","article-title":"Hesperidin potentiates the neuroprotective effects of diazepam and gabapentin against pentylenetetrazole-induced convulsions in mice: Possible behavioral, biochemical and mitochondrial alterations","volume":"46","author":"Kumar","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0042-112364","article-title":"Potential contribution of antioxidant mechanism in the defensive effect of lycopene against partial sciatic nerve ligation induced behavioral, biochemical and histopathological modification in wistar rats","volume":"66","author":"Goel","year":"2016","journal-title":"Drug Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s10753-014-9913-2","article-title":"Gabapentin, a synthetic analogue of gamma aminobutyric acid, reverses systemic acute inflammation and oxidative stress in mice","volume":"37","author":"Dias","year":"2014","journal-title":"Inflammation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jnen\/nly119","article-title":"Neuroprotective effects of gabapentin against cerebral ischemia reperfusion-induced neuronal autophagic injury via regulation of the PI3K\/Akt\/mTOR signaling pathways","volume":"78","author":"Yan","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopha.2017.08.125","article-title":"Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K\/Akt\/mTOR signaling pathway in rats with traumatic brain injury","volume":"95","author":"Shen","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/jbcpp-2012-0004","article-title":"The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain","volume":"23","author":"Khadrawy","year":"2012","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"da Cunha Leal, P., Moura, E.C.R., Cossetti, R.J.D., do Nascimento, J.R., Bog\u00e9a Serra, I.C.P., de Paulo Ribeiro, B., \u00c1lvares Marques Vale, A., de Azevedo dos Santos, A.P.S., do Nascimento, F.R.F., and Sakata, R.K. (2019). High dose gabapentin does not alter tumor growth in mice but reduces arginase activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich ascites. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-019-4103-9"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2017.08.013","article-title":"Extracellular superoxide dismutase and its role in cancer","volume":"112","author":"Griess","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1528-1157.44.s10.5.x","article-title":"An in vitro study of new antiepileptic drugs and astrocytes","volume":"44","author":"Pavone","year":"2003","journal-title":"Epilepsia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0271678X17743669","article-title":"Inhibition of GABA Transporters Fails to Afford Significant Protection Following Focal Cerebral Ischemia","volume":"38","author":"Lie","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainres.2016.12.032","article-title":"Antiepileptic drugs prevent seizures in hyperbaric oxygen: A novel model of epileptiform activity","volume":"1657","author":"Demchenko","year":"2017","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1152\/jn.01003.2006","article-title":"Superoxide (\u00b7O2\u2212) Production in CA1 Neurons of rat hippocampal slices exposed to graded levels of oxygen","volume":"98","author":"Putnam","year":"2007","journal-title":"J. Neurophysiol."},{"key":"ref_67","first-page":"169","article-title":"Nitric oxide amplifies the excitatory to inhibitory neurotransmitter imbalance accelerating oxygen seizures","volume":"33","author":"Demchenko","year":"2006","journal-title":"Undersea Hyperb. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/00498254.2015.1118774","article-title":"Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells","volume":"46","author":"Sugiyama","year":"2015","journal-title":"Xenobiotica"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1358\/mf.2004.26.5.831325","article-title":"The effects of oxcarbazepine on oxidative stress in epileptic patients","volume":"26","author":"Bolayir","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.seizure.2010.12.006","article-title":"Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice","volume":"20","author":"Agarwal","year":"2011","journal-title":"Seizure"},{"key":"ref_72","first-page":"6","article-title":"Protective effect of topiramate on hyperglycemia-induced cerebral oxidative stress, Pericyte loss and learning behavior in diabetic mice","volume":"1","author":"Price","year":"2015","journal-title":"Int. Libr. Diabetes Metab."},{"key":"ref_73","first-page":"598493","article-title":"Modulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): Evidence in humans and experimental models","volume":"2013","author":"Sampieri","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2010.06794.x","article-title":"Cocaine causes memory and learning impairments in rats: Involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate","volume":"114","author":"Muriach","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.45.3.456","article-title":"Aplastic anemia in a patient receiving felbamate for complex partial seizures","volume":"45","author":"Pennell","year":"1995","journal-title":"Neurology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2006.06.020","article-title":"Felbamate: Consensus of current clinical experience","volume":"71","author":"Pellock","year":"2006","journal-title":"Epilepsy Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/jbcpp-2016-0034","article-title":"Comparative studies on the effects of clinically used anticonvulsants on the oxidative stress biomarkers in pentylenetetrazole-induced kindling model of epileptogenesis in mice","volume":"28","author":"Mazhar","year":"2017","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1523\/JNEUROSCI.4521-08.2009","article-title":"SV2 renders primed synaptic vesicles competent for Ca2+-induced exocytosis","volume":"29","author":"Chang","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/mol.111.076687","article-title":"The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway","volume":"82","author":"Vogl","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eplepsyres.2018.01.004","article-title":"Effect of levetiracetam on extracellular amino acid levels in the dorsal hippocampus of rats with temporal lobe epilepsy","volume":"140","author":"Torreblanca","year":"2018","journal-title":"Epilepsy Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fphar.2016.00210","article-title":"A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release","volume":"7","author":"Tokudome","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1528-1167.2006.00973.x","article-title":"Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam","volume":"48","author":"Carunchio","year":"2007","journal-title":"Epilepsia"},{"key":"ref_85","first-page":"507","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpainsymman.2018.07.012","article-title":"Levetiracetam","volume":"56","author":"Howard","year":"2018","journal-title":"J. Pain Symptom Manag."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0971-5916.193296","article-title":"Effect of lamotrigine, levetiracetam & topiramate on neurobehavioural parameters & oxidative stress in comparison with valproate in rats","volume":"144","author":"Sarangi","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2019.03.009","article-title":"Effects of levetiracetam and valproic acid treatment on liver function tests, plasma free carnitine and lipid peroxidation in childhood epilepsies","volume":"153","author":"Haznedar","year":"2019","journal-title":"Epilepsy Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-4159.2009.05897.x","article-title":"Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival","volume":"109","author":"Niizuma","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eplepsyres.2009.09.020","article-title":"Mitochondria, oxidative stress, and temporal lobe epilepsy","volume":"88","author":"Waldbaum","year":"2010","journal-title":"Epilepsy Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.envpol.2019.05.063","article-title":"A transcriptomics-based analysis of the toxicity mechanisms of gabapentin to zebrafish embryos at realistic environmental concentrations","volume":"251","author":"He","year":"2019","journal-title":"Environ. Pollut."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1039\/C8RA04250K","article-title":"The assessment of the eco-toxicological effect of gabapentin on early development of zebrafish and its antioxidant system","volume":"8","author":"Li","year":"2018","journal-title":"RSC Adv."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuint.2009.01.024","article-title":"Diazepam neuroprotection in excitotoxic and oxidative stress involves a mitochondrial mechanism additional to the GABAAR and hypothermic effects","volume":"55","author":"Sarnowska","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10495-005-6064-9","article-title":"Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis","volume":"10","author":"Jorda","year":"2005","journal-title":"Apoptosis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3873\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:35:55Z","timestamp":1760121355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":95,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24043873"],"URL":"https:\/\/doi.org\/10.3390\/ijms24043873","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}